Nuclear Oncology in Cancer Imaging 2011
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Kaira K, Sunaga N, Ishizuka T, Shimizu K, Yamamoto N
. The role of [¹⁸F]fluorodeoxyglucose positron emission tomography in thymic epithelial tumors. Cancer Imaging. 2011; 11:195-201.
PMC: 3266585.
DOI: 10.1102/1470-7330.2011.0028.
View
2.
Callahan J, Kron T, Schneider-Kolsky M, Hicks R
. The clinical significance and management of lesion motion due to respiration during PET/CT scanning. Cancer Imaging. 2011; 11:224-36.
PMC: 3266588.
DOI: 10.1102/1470-7330.2011.0031.
View
3.
Akosman C, Alan Selcuk N, Ordu C, Ercan S, Ekici I, Oyan B
. Unicentric mixed variant Castleman disease associated with Hashimoto disease: the role of PET/CT in staging and evaluating response to the treatment. Cancer Imaging. 2011; 11:52-5.
PMC: 3205753.
DOI: 10.1102/1470-7330.2011.0011.
View
4.
Jindal T, Kumar A, Venkitaraman B, Meena M, Kumar R, Malhotra A
. Evaluation of the role of [18F]FDG-PET/CT and [68Ga]DOTATOC-PET/CT in differentiating typical and atypical pulmonary carcinoids. Cancer Imaging. 2011; 11:70-5.
PMC: 3205752.
DOI: 10.1102/1470-7330.2011.0010.
View
5.
Kaemmerer D, Khatib-Chahidi K, Baum R, Horsch D, Presselt N, Sanger J
. Concomitant lung and gastroenteropancreatic neuroendocrine tumors and the value of gallium-68 PET/CT. Cancer Imaging. 2011; 11:179-83.
PMC: 3266592.
DOI: 10.1102/1470-7330.2011.0035.
View